Core Insights - Net profit is a crucial indicator of a company's financial health, reflecting its ability to convert sales into profits [1] - A low profit margin indicates higher risks, while companies like Catalyst Pharmaceuticals, Gambling.com, Orion Group, and BrainsWay demonstrate solid net profit margins [2] Financial Metrics - Net Profit Margin is calculated as Net Profit divided by Sales, multiplied by 100, serving as a reference for operational strength and cost control [3] - A higher net profit is essential for rewarding stakeholders and attracting investors and skilled employees, providing a competitive edge [4] Investment Considerations - Net profit margin offers clarity on a company's business model, but it varies significantly across industries, making comparisons challenging [5][6] - Companies that grow through debt may face higher interest expenses, which can negatively impact net profit, complicating performance analysis [6] Investment Strategy - A healthy net profit margin and solid EPS growth are key elements for a successful business model [7] - Screening parameters include a net margin of at least 0%, positive EPS growth, and a broker rating of 1, indicating strong bullishness [8] Selected Companies - Catalyst Pharmaceuticals (CPRX) has a Zacks Rank of 1 and a VGM Score of A, with a revised earnings estimate of $2.25 per share for 2025 and an average surprise of 28.2% over the last four quarters [10][11] - Gambling.com (GAMB) also holds a Zacks Rank of 1 and a VGM Score of A, with a revised earnings estimate of $1.17 per share for 2025 and an average surprise of 68.7% [12] - Orion Group (ORN) has a Zacks Rank of 1 and a VGM Score of B, with a revised earnings estimate of $0.17 per share for 2025, although it has an average surprise of -104.4% [13][14] - BrainsWay (BWAY) carries a Zacks Rank of 2 and a VGM Score of A, with a revised earnings estimate of $0.31 per share for 2025 and an average surprise of 153.3% [15][16]